Follow WallStreetBlips on Twitter
GlaxoSmithKline
|
Add as Favorite |
vsinvestor.com - 20 days ago
—
vsinvestor.com —
Nabi Biopharmaceuticals (NASDAQ: NABI) is soaring on a
report that it and GlaxoSmithKline (NYSE: GSK) have entered...
into an agreement for its NicVAX, a nicotine conjugate candidate vaccine for the treatment of nicotine addiction and the prevention of ...
(more)
Nabi Smoking (NABI, GSK)
Comments
vote down
24/7 Wall St.
found this 20 days agofound this
|
GlaxoSmithKline Latest Blog Posts |
